RPRX – royalty pharma plc - class a ordinary shares (US:NASDAQ)

News

Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty Pharma [Yahoo! Finance]
Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21 [Yahoo! Finance]
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Royalty Pharma Declares Second Quarter 2024 Dividend
Royalty Pharma plc (NASDAQ: RPRX) had its price target lowered by analysts at Bank of America Co. from $40.00 to $38.00. They now have a "buy" rating on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com